Effects of recombinant human canstatin protein in the treatment of pancreatic cancer

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 41

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

489

HTML

2498

Figures (1-5)

310

Sum=3297

Nov 7, 2006 (publication date) through Feb 11, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Nov 7, 2006; 12(41): 6652-6657
Published online Nov 7, 2006. doi: 10.3748/wjg.v12.i41.6652

Full Size Figure Download Figure

Figure 1 Amplification products of human canstatin. Lane M: DNA marker; Lane 1: RT-PCR products.

Citation: He XP, Li ZS, Zhu RM, Tu ZX, Gao J, Pan X, Gong YF, Jin J, Man XH, Wu HY, Xu AF. Effects of recombinant human canstatin protein in the treatment of pancreatic cancer. World J Gastroenterol 2006; 12(41): 6652-6657
URL: https://www.wjgnet.com/1007-9327/full/v12/i41/6652.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i41.6652